Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-time evaluation of macozinone activity against Mycobacterium tuberculosis through bacterial nanomotion analysis.

Autor: Vocat A; Resistell AG, Muttenz, Switzerland.; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Luraschi-Eggemann A; Resistell AG, Muttenz, Switzerland., Antoni C; Innovative Medicines for Tuberculosis (iM4TB), Lausanne, Switzerland., Cathomen G; Resistell AG, Muttenz, Switzerland., Cichocka D; Resistell AG, Muttenz, Switzerland., Greub G; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Riabova O; Research Centre of Biotechnology RAS, Leninsky Prospect, Moscow, Russia., Makarov V; Research Centre of Biotechnology RAS, Leninsky Prospect, Moscow, Russia., Opota O; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Mendoza A; Innovative Medicines for Tuberculosis (iM4TB), Lausanne, Switzerland., Cole ST; Innovative Medicines for Tuberculosis (iM4TB), Lausanne, Switzerland., Sturm A; Resistell AG, Muttenz, Switzerland.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Nov 27, pp. e0131824. Date of Electronic Publication: 2024 Nov 27.